BACK TO ALL SVV STUDIES
pennmed_4in_color.jpg
logo_v.2-1-01.jpg
UniversityofPennsylvania_FullLogo_RGB_ca

  • Home

  • About Us

  • Meet the Team

  • Research

    • Active Research Studies
    • Completed Research Studies
    • Being a Research Participant
    • Publications

  • Patient Care

    • Schedule an Appointment
    • GCA Fast Track
    • Relapsing Polychondritis Program
    • Patient Resources

  • Donate

  • Contact

  • More

    Use tab to navigate through the menu items.

    MANDARA: Benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA)

    CURRENTLY ENROLLING: yes

    BACK TO ALL ACTIVE STUDIES

    © 2020 by Penn Vasculitis Center. Proudly created with Wix.com